key: cord-0858510-h1mm5n71
authors: Natalia, Chebotareva; Svetlana, Berns; Tatyana, Androsova; Sergey, Moiseev
title: Risk factors for invasive and non-invasive ventilatory support and mortality in hospitalized patients with COVID-19
date: 2021-04-30
journal: Med Intensiva
DOI: 10.1016/j.medin.2021.04.002
sha: bf35eee72561ee6377b9144d3fc053e8bd4d0551
doc_id: 858510
cord_uid: h1mm5n71

nan

The mortality rates in patients with COVID-19 pneumonia depend largely on the need to start oxygen supply and the level of respiratory support. In a nationwide study of 1522 consecutive patients with COVID-19 admitted to the Russian intensive care units, the mortality rate was low in patients requiring oxygen supply only (10.1%) and significantly higher in patients who required non-invasive (36.8%) or invasive (76.5%) ventilation [1] . Recently, P. Ramírez et al. [2] published data on ARDS patients admitted to a medical critical care unit (MCCU) and showed the lower mortality (23.5%).

The aim of our retrospective study was to investigate the risk factors for NI/I-VS and mortality in 1268 hospitalized patients (638 males and 630 females; median age 63 [52-75] years) with COVID-19 who had completed their hospital stay (death or recovery) from April to June 2020. A diagnosis of COVID-19 was confirmed by polymerase chain reaction on nasopharyngeal swab and/or chest CT (4 or 5 on CO-RADS scale). The extent of lung involvement on CT was classified as none (0%), minimal (1-25%), mild (26-50%), moderate (51-75%), or severe (76-100%) ( Table 1) .

A total of 731 (57.6%) of 1268 patients required supplemental oxygen. Most of them received oxygen therapy via nasal cannulas, whereas NI/I-VS was started in 119 (9.4%) patients (Table  1) . Among patients on NI/I-VS, the mortality rate was significantly higher than among patients who did not require oxygen therapy or were treated with oxygen via nasal cannulas (59.7% and 7.9%, respectively, OR 29.004 [19.71-42.68], p<0.001). In univariate logistic model, the following factors were associated with the requirement for NI/I-VS: the maximum CRP and Ddimer levels, prolonged APTT, the extent of bilateral lung involvement, arterial hypertension, coronary heart disease, and diabetes mellitus. Among them, CRP, aPTT, D-dimer, the extent of lung involvement, and arterial hypertension retained statistical significance in multivariate logistic regression model (Table 2 ).

Our findings showed that the need in NI/I-VS was associated with a seven-fold increase in the mortality rates in the large cohort of the consecutive hospitalized patients with COVID-19. The lower mortality in work Ramírez et al. [2] might be explained by therapy with steroids and tocilizumab in almost all patients (95.5%).

Lung pathology in COVID-19 shows extensive alveolar and interstitial inflammation and microvascular thrombosis. Infection, coagulation factors and innate immune effector systems (macrophages, neutrophils and the complement system) interact in a process termed immunothrombosis (or thromboinflammation), which is the convergence of thrombosis and inflammation [3] . The role of increased levels of inflammatory markers as well as D-dimer in the development of acute respiratory distress syndrome confirms this concept [4, 5] .

In conclusion, systemic inflammatory response and coagulation disorders, as well as arterial hypertension were associated with the requirement for NI/I-VS in hospitalized COVID-19 patients.

The study was approved by the local ethics committee of the Zhadkevich City Clinical Hospital, Moscow (approval certificate no. 07-20).

The authors do not have any conflicts of interest to declare.

None. Invasive ventilatory support 78 (6.1)

Abbreviations: IQRinterquartile range, BMIbody mass index Abbreviations: aPTTactivated partial tromboplastin time, CHDcoronary heart disease. CRP -C-reactive protein, CTcomputer tomography, COPDchronic obstructive pulmonary disease

Outcomes of intensive care unit patients with COVID-19: a nationwide analysis in Russia

Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia

Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated intravascular coagulation. Autoimmune Rev

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Novel risk scoring system for predicting acute respiratory distress syndrome among hospitalized patients with coronavirus disease